Drug Discovery Research
Mochida Pharmaceutical's drug discovery research has made a fresh start with a major overhaul of its existing organization and strategy. In particular, we are focusing on "oligonucleotide drugs" to create innovative new drugs that address unmet medical needs.
The Drug Discovery Research Center, located in Gotemba, Shizuoka, primarily focuses on compound synthesis and biological evaluation, while the CMC Research Center, located in Fujieda, Shizuoka, conducts formulation studies and CMC research. In order to build a competitive research team, we are actively recruiting highly specialized personnel and strengthening our research infrastructure. All of our researchers are working together to maximize the excellent properties of oligonucleotide drugs and to create original and unprecedented pharmaceuticals.
Development
We have been successful every year in obtaining manufacturing and marketing approval by advancing clinical development of our developmental products on schedule. We are proactively working on challenging developments for rare intractable diseases and to establish usage and dosage for children that have not been actively pursued domestically.